Cure8 research brief
This review highlights probiotic and synbiotic approaches centered on L. plantarum that aim to rebalance gut microbiota and support the intestinal barrier—areas of direct interest to people with IBD seeking adjunctive, food-based strategies.
It summarizes mechanisms and technological advances that could shape future adjunct therapies.
Adult patients with IBD interested in probiotics or diet-based adjuncts, clinicians advising on complementary therapies, and researchers studying microbiome-based treatments and probiotic delivery systems.
This review examines Lactiplantibacillus plantarum (L. plantarum) as a probiotic candidate for IBD, summarizing mechanistic studies that report effects on immune regulation, oxidative stress, intestinal barrier protection, and microbiota balance.
It also covers synbiotic strategies (combining probiotics with prebiotics) and delivery technologies aimed at improving probiotic stability and targeting. The authors frame L.
plantarum as a multi-target adjunctive approach rather than a replacement for conventional IBD medicines, and discuss the need for translating basic research into clinical applications and precision probiotic strategies. Practical takeaways in the review include potential benefits of synbiotics and novel delivery systems to enhance L.
plantarum’s effects, but the article emphasizes that more translational and clinical work is needed before routine clinical use can be recommended. This is a narrative review of preclinical and some clinical literature; it synthesizes existing studies rather than reporting a single new trial.
This is a full-text academic review that synthesizes preclinical and clinical studies. It does not constitute new clinical trial evidence; findings described are from prior studies of varying designs and quality. Individual probiotic strains can differ in effects, and clinical recommendations require controlled trials.
Review the original publication for the complete reporting, methods, and context.
Conflict statement: The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Dietary patterns like the Mediterranean diet may reduce inflammation and improve quality of life for people with Crohn’s disease by beneficially altering the gut microbiome and inflammatory markers. That could offer a...
The study suggests that combining different fermentable fibers may steer the gut microbiome toward more butyrate-producing bacteria and away from pro-inflammatory lineages—changes that could be relevant to IBD-related...
People with IBD often receive general advice to eat more fiber, but certain purified fibers or fiber-enriched foods may help some people while worsening inflammation in others. Research that teases apart fiber types and...
